V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019466 | 270008131 | 1.75 | 61.7 | Disease modification (D) | 2018-05-02 | 2018-05-03 | Brentuximab | 02 | N | 270011914 | BRENTUXIMAB |
| 270019467 | 270008137 | null | null | Palliative (P) | 2016-08-06 | 2016-08-06 | Brentuximab Vedotin | N | null | 270011920 | BRENTUXIMAB |
| 270019468 | 270008142 | 1.84 | 60.3 | Adjuvant (A) | 2014-08-16 | 2014-09-06 | CAPECITABINE + OXALIPLATIN | 02 | N | 270011935 | CAPECITABINE + OXALIPLATIN |
| 270019469 | 270008159 | 1.73 | 128.4 | Disease modification (D) | 2015-05-20 | 2015-05-20 | Brentuximab | 02 | null | 270011982 | BRENTUXIMAB |
| 270019470 | 270019586 | 1.78 | 98.7 | Palliative (P) | 2017-12-11 | 2018-02-06 | Capecitabine | N | N | 270012061 | CAPECITABINE |
| 270019471 | 270008194 | null | 73.4 | Palliative (P) | 2014-05-08 | 2014-05-09 | Capecitabine | N | N | 270012098 | CAPECITABINE |
| 270019472 | 270008218 | 1.7 | 91.2 | Curative (C) | 2014-07-14 | 2014-09-13 | COPP + Dacarbazine | N | N | 270012187 | COPP + DACARBAZINE |
| 270019473 | 270013939 | 1.69 | 94.8 | Palliative (P) | 2015-12-05 | 2015-12-26 | CETUXIMAB | 02 | N | 270012431 | CETUXIMAB |
| 270019474 | 270008318 | null | 76.1 | Curative (C) | 2016-10-14 | 2016-10-18 | COPP + Dacarbazine | 02 | N | 270012463 | COPP + DACARBAZINE |
| 270019475 | 270008345 | 1.8 | 95.1 | Palliative (P) | 2013-04-04 | 2014-04-15 | CETUXIMAB | N | N | 270012525 | CETUXIMAB |
| 270019476 | 270016643 | 0 | 29 | Curative (C) | null | 2014-04-13 | COPP + Dacarbazine | N | N | 270012579 | COPP + DACARBAZINE |
| 270019477 | 270008371 | 1.75 | 55 | Curative (C) | 2017-08-12 | 2017-11-06 | COPP + Dacarbazine | 02 | N | 270012592 | COPP + DACARBAZINE |
| 270019478 | 270008377 | 1.66 | 57 | Palliative (P) | 2017-05-27 | 2017-11-04 | CETUXIMAB | 02 | N | 270012599 | CETUXIMAB |
| 270019479 | 270008380 | null | 56.1 | Palliative (P) | 2017-03-15 | 2017-03-15 | Cetuximab 14 day | 02 | N | 270012612 | CETUXIMAB |
| 270019480 | 270008392 | 1.9 | 43.7 | Curative (C) | 2017-12-23 | 2017-12-29 | Cetuximab 14 day | null | N | 270012660 | CETUXIMAB |
| 270019481 | 270008416 | 1.6 | 59.2 | Adjuvant (A) | 2016-12-05 | 2016-12-09 | COPP + Dacarbazine | 02 | N | 270012720 | COPP + DACARBAZINE |
| 270019482 | 270008424 | 1.83 | 78 | Palliative (P) | 2017-05-19 | 2017-05-20 | Cetuximab 7 day (Cycle 1) | N | N | 270012726 | CETUXIMAB |
| 270019483 | 270008429 | 1.56 | 72.9 | Curative (C) | 2013-11-17 | 2014-01-12 | COPP + Dacarbazine | N | null | 270012737 | COPP + DACARBAZINE |
| 270019484 | 270008437 | 1.8 | 94.8 | Curative (C) | 2013-09-25 | 2013-12-28 | CETUXIMAB | N | N | 270012755 | CETUXIMAB |
| 270019485 | 270008464 | 0 | 89 | Curative (C) | 2016-05-28 | 2016-05-28 | HD EuroNet-PHL-C1 Relapsed IEP | N | N | 270012832 | TRIAL |
| 270019486 | 270008487 | null | 56 | Curative (C) | 2017-05-21 | 2018-07-10 | Cetuximab 14 day | N | null | 270012909 | CETUXIMAB |
| 270019487 | 270016680 | 1.7 | 76.6 | Curative (C) | 2017-05-12 | 2017-05-21 | BEACOPP | N | N | 270012948 | BEACOPP |
| 270019488 | 270008504 | 0 | 78.9 | Palliative (P) | 2014-12-25 | 2015-02-28 | Trial Unspecified | N | null | 270012975 | TRIAL |
| 270019489 | 270008513 | 0 | 95 | null | 2015-11-01 | 2015-11-04 | COPP + Dacarbazine | N | N | 270013020 | COPP + DACARBAZINE |
| 270019490 | 270008550 | 1.75 | 85 | Curative (C) | 2017-04-04 | 2017-04-04 | BEACOPP-14 | N | null | 270013196 | BEACOPP |
| 270019491 | 270008560 | 1.67 | 50 | Curative (C) | 2016-11-29 | 2017-01-28 | HD EuroNet-PHL-C1 COPDAC | N | null | 270013228 | TRIAL |
| 270019492 | 270008585 | 0 | 64 | Adjuvant (A) | 2015-03-16 | 2015-03-18 | COPP + Dacarbazine | N | null | 270013366 | COPP + DACARBAZINE |
| 270019493 | 270008600 | 1.8 | 59.6 | Curative (C) | 2017-03-05 | 2017-03-05 | Escalated BEACOPP | N | null | 270013451 | BEACOPP |
| 270019494 | 270008612 | 1.68 | 56.1 | Disease modification (D) | 2016-12-08 | 2016-12-11 | Escalated BEACOPP | N | Y | 270013483 | BEACOPP |
| 270019495 | 270008620 | null | 60.5 | Palliative (P) | 2017-02-20 | 2017-02-24 | HD EuroNet-PHL-C1 COPDAC | 01 | N | 270013509 | TRIAL |
| 270019496 | 270008634 | null | 38.4 | Curative (C) | 2016-10-23 | 2016-10-23 | HD EuroNet-PHL-C1 COPDAC | N | null | 270013582 | TRIAL |
| 270019497 | 270016712 | 0 | null | Curative (C) | 2017-09-30 | 2017-09-30 | Trial Unspecified | N | N | 270013590 | TRIAL |
| 270019498 | 270008651 | 0 | 41.9 | Curative (C) | 2015-10-12 | 2015-10-12 | COPP + Dacarbazine | null | null | 270013762 | COPP + DACARBAZINE |
| 270019499 | 270008678 | null | 61.5 | Curative (C) | 2017-12-27 | 2017-12-31 | CETUXIMAB | 02 | N | 270013969 | CETUXIMAB |
| 270019500 | 270018245 | 1.49 | 27.1 | Curative (C) | 2017-10-16 | 2017-12-24 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013992 | TRIAL |
| 270019501 | 270008707 | 1.86 | 66.8 | Neo-adjuvant (N) | 2015-01-23 | 2015-04-14 | Escalated BEACOPP | N | N | 270014097 | BEACOPP |
| 270019502 | 270008714 | 1.57 | 74 | Curative (C) | 2014-06-24 | 2014-06-24 | COPP + Dacarbazine | N | N | 270014163 | COPP + DACARBAZINE |
| 270019503 | 270008722 | 1.86 | 120.8 | Curative (C) | 2016-08-14 | 2016-08-14 | Trial Unspecified | 01 | N | 270014196 | TRIAL |
| 270019504 | 270008729 | 1.54 | 44.9 | Neo-adjuvant (N) | 2016-05-03 | 2016-05-10 | CETUXIMAB | null | N | 270014220 | CETUXIMAB |
| 270019505 | 270008744 | 1.7 | 70 | Palliative (P) | 2018-12-23 | 2019-03-11 | Trial Unspecified | null | N | 270014274 | TRIAL |
| 270019506 | 270008756 | 1.72 | 61.7 | Curative (C) | 2014-10-24 | 2014-10-28 | COPP + Dacarbazine | 02 | N | 270014363 | COPP + DACARBAZINE |
| 270019507 | 270014142 | 0 | 120.8 | Palliative (P) | 2018-01-09 | 2018-04-24 | COPP + Dacarbazine | N | Y | 270014409 | COPP + DACARBAZINE |
| 270019508 | 270018260 | 1.85 | 78.8 | null | 2016-05-23 | 2016-06-05 | HD EuroNet-PHL-C1 COPDAC | N | N | 270014418 | TRIAL |
| 270019509 | 270008784 | null | null | Curative (C) | 2018-01-27 | 2018-04-02 | COPP + Dacarbazine | 02 | N | 270014427 | COPP + DACARBAZINE |
| 270019510 | 270014147 | 0 | 90 | Curative (C) | 2018-01-17 | 2018-03-08 | HD EuroNet-PHL-C1 COPDAC | 02 | null | 270014444 | TRIAL |
| 270019511 | 270019623 | 1.6 | 119.87 | Curative (C) | 2018-08-10 | 2018-10-06 | CETUXIMAB | N | N | 270014445 | CETUXIMAB |
| 270019512 | 270008808 | 1.42 | 95.2 | Curative (C) | 2016-04-07 | 2016-06-19 | COPP + Dacarbazine | N | N | 270014474 | COPP + DACARBAZINE |
| 270019513 | 270008818 | 0 | 64 | Palliative (P) | 2019-02-19 | 2019-02-20 | HD EuroNet-PHL-C1 COPDAC | N | null | 270014494 | TRIAL |
| 270019514 | 270008823 | null | 100.6 | Palliative (P) | 2015-10-13 | 2015-12-12 | Cetuximab 14 day | 2 | null | 270014508 | CETUXIMAB |
| 270019515 | 270008832 | 1.57 | 64 | Curative (C) | 2015-02-16 | 2015-02-20 | LEAM | N | N | 270014528 | LEAM |